BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8280062)

  • 1. Structure and contribution to the heparin cofactor II-mediated inhibition of thrombin of naturally oversulphated sequences of dermatan sulphate.
    Mascellani G; Liverani L; Bianchini P; Parma B; Torri G; Bisio A; Guerrini M; Casu B
    Biochem J; 1993 Dec; 296 ( Pt 3)(Pt 3):639-48. PubMed ID: 8280062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative influence of different disulphate disaccharide clusters on the HCII-mediated inhibition of thrombin by dermatan sulphates of different origins.
    Mascellani G; Liverani L; Prete A; Guppola PA; Bergonzini G; Bianchini P
    Thromb Res; 1994 Jun; 74(6):605-15. PubMed ID: 8091403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active site for heparin cofactor II in low molecular mass dermatan sulfate. Contribution to the antithrombotic activity of fractions with high affinity for heparin cofactor II.
    Mascellani G; Liverani L; Parma B; Bergonzini G; Bianchini P
    Thromb Res; 1996 Oct; 84(1):21-32. PubMed ID: 8885144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-Acetylgalactosamine 4,6-O-sulfate residues mediate binding and activation of heparin cofactor II by porcine mucosal dermatan sulfate.
    Halldórsdóttir AM; Zhang L; Tollefsen DM
    Glycobiology; 2006 Aug; 16(8):693-701. PubMed ID: 16624894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of dermatan sulfate active site for heparin cofactor II by 1H nuclear magnetic resonance spectroscopy.
    Mascellani G; Liverani L; Prete A; Bergonzini G; Bianchini P; Torri G; Bisio A; Guerrini M; Casu B
    Anal Biochem; 1994 Nov; 223(1):135-41. PubMed ID: 7695089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural characterization and antithrombin activity of dermatan sulfate purified from marine clam Scapharca inaequivalvis.
    Volpi N; Maccari F
    Glycobiology; 2009 Apr; 19(4):356-67. PubMed ID: 19056786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of a dermatan sulfate hexasaccharide that binds to heparin cofactor II with high affinity.
    Maimone MM; Tollefsen DM
    J Biol Chem; 1990 Oct; 265(30):18263-71. PubMed ID: 2211700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant dermatan sulfate is a potent activator of heparin cofactor II-dependent inhibition of thrombin.
    Tykesson E; Maccarana M; Thorsson H; Liu J; Malmström A; Ellervik U; Westergren-Thorsson G
    Glycobiology; 2019 Jun; 29(6):446-451. PubMed ID: 30869126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural heterogeneity of dermatan sulfate chains: correlation with heparin cofactor II activating properties.
    Denti A; Sini P; Tira ME; Balduini C
    Thromb Res; 1995 Jul; 79(2):187-98. PubMed ID: 7676405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between the structure of dermatan sulfate derivatives and their antithrombotic activities.
    Du HY; Ji SL; Song HF; Ye QN; Cao JC
    Thromb Res; 2007; 119(3):377-84. PubMed ID: 17097136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dermatan sulfate in tunicate phylogeny: order-specific sulfation pattern and the effect of [→4IdoA(2-sulfate)β-1→3GalNAc(4-sulfate)β-1→] motifs in dermatan sulfate on heparin cofactor II activity.
    Kozlowski EO; Lima PC; Vicente CP; Lotufo T; Bao X; Sugahara K; Pavão MS
    BMC Biochem; 2011 May; 12():29. PubMed ID: 21619699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A unique dermatan sulfate-like glycosaminoglycan from ascidian. Its structure and the effect of its unusual sulfation pattern on anticoagulant activity.
    Pavão MS; Mourão PA; Mulloy B; Tollefsen DM
    J Biol Chem; 1995 Dec; 270(52):31027-36. PubMed ID: 8537360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of thrombin inhibition by heparin cofactor II in the presence of dermatan sulphates, native or oversulphated, and a heparin-like dextran derivative.
    Maaroufi RM; Jozefowicz M; Tapon-Bretaudière J; Jozefonvicz J; Fischer AM
    Biomaterials; 1997 Feb; 18(4):359-66. PubMed ID: 9068899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombin activity and disaccharide composition of dermatan sulfate from different bovine tissues.
    Osborne SA; Daniel RA; Desilva K; Seymour RB
    Glycobiology; 2008 Mar; 18(3):225-34. PubMed ID: 18156656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of dermatan sulfate with high heparin cofactor II-mediated thrombin-inhibitory activity from porcine spleen.
    Munakata H; Hsu CC; Kodama C; Aikawa J; Sakurada M; Ototani N; Isemura M; Yosizawa Z; Hayashi N
    Biochim Biophys Acta; 1987 Sep; 925(3):325-31. PubMed ID: 3620505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural determination of sulfated tetrasaccharides and hexasaccharides containing a rare disaccharide sequence, -3GalNAc(4,6-disulfate)beta1-4IdoAalpha1-, isolated from porcine intestinal dermatan sulfate.
    Yamada S; Yamane Y; Sakamoto K; Tsuda H; Sugahara K
    Eur J Biochem; 1998 Dec; 258(2):775-83. PubMed ID: 9874247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interaction of glycosaminoglycans with heparin cofactor II: structure and activity of a high-affinity dermatan sulfate hexasaccharide.
    Tollefsen DM
    Adv Exp Med Biol; 1992; 313():167-76. PubMed ID: 1442260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1H-n.m.r. investigation of naturally occurring and chemically oversulphated dermatan sulphates. Identification of minor monosaccharide residues.
    Bossennec V; Petitou M; Perly B
    Biochem J; 1990 May; 267(3):625-30. PubMed ID: 2339978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of oligosaccharides from the chondroitin/dermatan sulfates. 1H-NMR and 13C-NMR studies of reduced trisaccharides and hexasaccharides.
    Huckerby TN; Nieduszynski IA; Giannopoulos M; Weeks SD; Sadler IH; Lauder RM
    FEBS J; 2005 Dec; 272(24):6276-86. PubMed ID: 16336265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular size of dermatan sulfate oligosaccharides required to bind and activate heparin cofactor II.
    Tollefsen DM; Peacock ME; Monafo WJ
    J Biol Chem; 1986 Jul; 261(19):8854-8. PubMed ID: 3755134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.